Plain-English translation of NCT06743308 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a screening tool called INPUT can help patients with stage 4 (advanced) lung cancer better understand their illness. The tool is completed during regular cancer clinic visits and asks questions about what you know and want to know about your condition. Researchers want to see if this simple screening process helps patients feel more informed and less confused about their diagnosis.
Many patients with advanced lung cancer feel confused or uncertain about their illness and what to expect. This trial exists to test whether a structured screening tool can help close that gap by making sure doctors understand what patients know and need to learn.
You likely qualify if…
You likely don't qualify if…
You will continue your regular cancer clinic visits at MD Anderson. If you are assigned to the screening group, you will complete the INPUT screening tool at each of your standard follow-up visits—this takes just a few minutes and involves answering questions about what you understand about your illness. The study lasts about 3 months, and researchers will track how your understanding of your condition changes over that time.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Enrollment target
~100 participants
Started
December 2024
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kayley M Ancy, MD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.